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Abstract
Background: Nervous tissues express various communication molecules including natriuretic
peptides,  i.e. Brain Natriuretic Peptide (BNP) and C-type Natriuretic Peptide (CNP). These
molecules share structural similarities with cyclic antibacterial peptides. CNP and to a lesser extent
BNP can modify the cytotoxicity of the opportunistic pathogen Pseudomonas aeruginosa. The
psychrotrophic environmental species Pseudomonas fluorescens also binds to and kills neurons and
glial cells, cell types that both produce natriuretic peptides. In the present study, we investigated
the sensitivity of Pseudomonas fluorescens to natriuretic peptides and evaluated the distribution and
variability of putative natriuretic peptide-dependent sensor systems in the Pseudomonas genus.
Results: Neither BNP nor CNP modified P. fluorescens MF37 growth or cultivability. However,
pre-treatment of P. fluorescens MF37 with BNP or CNP provoked a decrease of the apoptotic effect
of the bacterium on glial cells and an increase of its necrotic activity. By homology with eukaryotes,
where natriuretic peptides act through receptors coupled to cyclases, we observed that cell-
permeable stable analogues of cyclic AMP (dbcAMP) and cyclic GMP (8BcGMP) mimicked the effect
of BNP and CNP on bacteria. Intra-bacterial concentrations of cAMP and cGMP were measured
to study the involvement of bacterial cyclases in the regulation of P. fluorescens cytotoxicity by BNP
or CNP. BNP provoked an increase (+49%) of the cAMP concentration in P. fluorescens, and CNP
increased the intra-bacterial concentrations of cGMP (+136%). The effect of BNP and CNP on the
virulence of P. fluorescens was independent of the potential of the bacteria to bind to glial cells.
Conversely, LPS extracted from MF37 pre-treated with dbcAMP showed a higher necrotic activity
than the LPS from untreated or 8BcGMP-pre-treated bacteria. Capillary electrophoresis analysis
suggests that these different effects of the LPS may be due, at least in part, to variations in the
structure of the macromolecule.
Conclusion: These observations support the hypothesis that P. fluorescens responds to natriuretic
peptides through a putative sensor system coupled to a cyclase that could interfere with LPS
synthesis and thereby modify the overall virulence of the micro-organism.
Background
By the virtue of the size of their genome and the abun-
dance of regulatory genes, bacteria of the genus Pseu-
domonas can adapt to a multitude of environmental niches
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[1]. In addition, they express natural resistance to β-
lactamins and several disinfectants, and consequently the
opportunistic behaviour of Pseudomonas is problematic in
hospitals [2]. Pseudomonas aeruginosa is one of the micro-
organisms most commonly responsible for nosocomial
diseases and other fluorescent Pseudomonas  also cause
human infections [3,4]. Some psychrotrophic species,
such as Pseudomonas fluorescens, which are pathogens in
cold blood vertebrates [5], are also cytotoxic to mamma-
lian cells [6] and can generate virulent clinical strains able
to grow at 37°C [4]. P. fluorescens and P. aeruginosa possess
a specific affinity for neurons and glial cells and their
binding to the target cells is associated with apoptosis and
necrosis [6]. The action of Pseudomonas  on nerve cells
appears to be very specific [7] and mostly mediated by the
lipopolysaccharide (LPS) [8-10].
In the host, and particularly in the vicinity of nerve cells,
bacteria are exposed to multitude of information mole-
cules (including neurotransmitters and neurohormones).
The sensing of these eukaryotic signals may modulate the
physiology of the bacteria and may potentially modify
their cytotoxicity. Indeed, the physiology and virulence of
bacteria can be modulated by diverse small signal mole-
cules such as norepinephrine [11], epinephrine [12], neu-
ropeptides including somatostatin [13], melanocortin
peptides [14], immune modulators such as dynorphin
[15] and interferon-γ [16] and natriuretic peptides,
namely the brain natriuretic peptide (BNP) and the C-
type natriuretic peptide (CNP) [10]. We demonstrated
recently the existence of a putative natriuretic peptide sen-
sor in P. aeruginosa PAO1 [10]. Natriuretic peptides may
act in this bacterium through activation of a cyclase lead-
ing to an increase in the intra-bacterial cAMP concentra-
tion and to stimulation of the Vfr global regulator. The
resulting modulation of the cytotoxicity correlates with
major changes in the structure of the LPS. Biochemical
studies revealed that LPS extracted from P. fluorescens gen-
erally causes apoptosis whereas the LPS purified from P.
aeruginosa is a potent pro-necrosis factor [8]. These find-
ings and studies of the thermoregulation of virulence [17]
suggest a dissociation of the apoptotic and necrotic effects
of the endotoxins in the two species. P. aeruginosa and P.
fluorescens are closely related, but there has been no inves-
tigation of whether P. fluorescens carries a natriuretic pep-
tide sensor system. The results such an investigation
would provide information about the probability of
expression of similar systems in the group of fluorescent
Pseudomonas, and about interspecies factors of variability.
Here, we report a study of the effects of BNP and CNP on
the growth, adhesion potential and virulence of P. fluores-
cens in vitro using a model of primary cultures of glial cells.
The variations of bacterial cytotoxicity induced by BNP
and CNP were reproduced using cell permeable stable
analogs of cyclic nucleotides, molecules, naturally pro-
duced in eukaryotes upon coupling of the natriuretic pep-
tides to their receptors. We studied changes in intra-
bacterial concentrations of cAMP and cGMP after expo-
sure of the micro-organisms to BNP and CNP. We also
investigated the effects of stable analogs of the cyclic
nucleotides on the cytotoxicity and chemical properties of
bacterial LPS.
Results
In our experimental conditions at 28°C, Pseudomonas flu-
orescens MF37 multiplied rapidly, following an exponen-
tial growth curve until reaching stationary phase 6 hours
after the beginning of the experiment. Addition of BNP or
CNP (10-6 M) at the onset of the incubation or at the
beginning of the stationary phase did not modify the gen-
eral profile of the growth curve or the mean time required
for doubling of the bacterial population. Similarly, the
cultivability and colony forming potential of P. fluorescens
MF37 on solid substrate was unchanged by exposure of
the bacteria to BNP or CNP (10-6 M) (data not shown).
Effect of pre-treatment with natriuretic peptides on the 
potential of Pseudomonas fluorescens MF37 to provoke 
apoptosis in glial cells
The spontaneous nitrite (NO2
-) synthase activity of Pseu-
domonas fluorescens MF37 is very low (Fig. 1); conse-
quently, as previously demonstrated [17], NO2
-  ions
detected in the medium of cultures of glial cells exposed
to  P. fluorescens MF37 result from eukaryotic NO syn-
thases activated during the induction of the apoptotic
death of the glial cells. The concentration of NO- 
2 in the
medium following incubation of glial cells with P. fluores-
cens MF37 reached 26.5 ± 1.6 μM (n = 28). Pre-treatment
of P. fluorescens with natriuretic peptides (10-6 M for 5 h at
28°C) significantly decreased their capacity to provoke
NO synthesis by glial cells: the NO- 
2 concentration for
bacteria exposed to BNP was 18.3 ± 1.8 μM (31 % lower
than the control value; P < 0.001) and for those exposed
to CNP was 14.9 ± 2.7 μM (46 % lower than the control
value; P < 0.001) (Fig. 1).
Effect of pre-treatment of Pseudomonas fluorescens 
MF37 by natriuretic peptides on its potential to provoke 
necrosis in glial cells
Lactate dehydrogenase (LDH) is a stable cytosolic enzyme
in eukaryotic cells and is totally absent from the medium
when  Pseudomonas fluorescens MF37 is incubated alone
(Fig. 2); it can thus serve as a marker of eukaryotic cell
lysis. When glial cells were incubated alone a small
amount of LDH was recovered in the medium consistent
with only a small proportion of the population (4.5 ± 1.0
%; n = 20) undergoing necrosis during the incubation
period of 24 h. This indicates the good health and quality
of the glial cell cultures. Glial cells were then exposed to P.BMC Microbiology 2008, 8:114 http://www.biomedcentral.com/1471-2180/8/114
Page 3 of 11
(page number not for citation purposes)
fluorescens MF37 (106 CFU/ml): the percentage of the cell
population affected by necrosis reached 31.2 ± 3.4 %. Pre-
treatment of P. fluorescens with BNP or CNP (10-6 M; 5 h;
28°C) resulted in a significant increase in the number
glial cells affected by necrosis: 43.6 ± 4.8 % for bacteria
exposed to BNP (40 % more than for untreated bacteria;
P < 0.05) (Fig. 2) and 53.2 ± 5.1 % for bacteria treated
with CNP (71 % more than for untreated bacteria; P <
0.001) (Fig. 2).
Effect of pre-treatment of Pseudomonas fluorescens 
MF37 by stable analogues of cAMP and cGMP on its 
potential to provoke apoptosis and necrosis
The cytotoxicity of P. fluorescens was investigated after
exposure of the bacteria to dibutyryl cyclic AMP
(dbcAMP) or 8-bromo-cyclic GMP (8BcGMP) (10-5 M for
5 h at 28°C), two cell-permeable stable analogues of
cyclic AMP and cyclic GMP. As observed using natriuretic
peptides, pre-treatment of P. fluorescens with dbcAMP or
8BcGMP (10-5 M for 5 h at 28°C) significantly decreased
their capacity to provoke NO synthesis by glial cells: the
NO- 
2 concentration for bacteria exposed to dbcAMP was
Effect of brain natriuretic peptide (BNP) and C-type natriu- retic peptide (CNP) (10-6 M) on the apoptotic activity of  Pseudomonas fluorescens MF37 Figure 1
Effect of brain natriuretic peptide (BNP) and C-type 
natriuretic peptide (CNP) (10-6 M) on the apoptotic 
activity of Pseudomonas fluorescens MF37. The apop-
totic effect of the bacterium was determined by measure-
ment of the accumulation in the medium of NO2
- resulting 
from the activation of inducible NO synthase activity in glial 
cells. Values are expressed as the mean concentration of 
NO2
- produced by glial cells following exposure (24 h) to 
untreated (n = 28) or treated (n = 24 for BNP, and n = 15 for 
CNP) bacteria. Data are means of four independent experi-
ments. *** : Significantly different (P < 0.001). NS: Not signifi-
cantly different.
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Effect of brain natriuretic peptide (BNP) and C-type natriu- retic peptide (CNP) (10-6 M) on the necrotic activity of Pseu- domonas fluorescens MF37 Figure 2
Effect of brain natriuretic peptide (BNP) and C-type 
natriuretic peptide (CNP) (10-6 M) on the necrotic 
activity of Pseudomonas fluorescens MF37. The necrotic 
effect of the bacterium was determined by measurement of 
the accumulation in the medium of lactate dehydrogenase 
(LDH) resulting from rupture of the cytoplasmic membrane 
of glial cells and consequently release of the enzyme. Values 
are expressed as the mean concentration of LDH in the cul-
ture medium after 24 h of incubation with untreated (n = 20) 
or treated (n = 20 for BNP, and n = 17 for CNP) bacteria. 
Data are means for four independent experiments. * : Signifi-
cantly different (P < 0.05). *** : Significantly different (P < 
0.001).
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11.2 ± 0.7 μM (50 % lower than the control value; P <
0.001) and for those exposed to 8BcGMP was 11.6 ± 0.8
μM (48 % lower than the control value; P < 0.001) (Fig.
3A). In contrast, a similar pre-treatment with dbcAMP or
8BcGMP increased the necrotic potential of the bacteria
by +42.1 ± 5.1 % and +36.8 ± 4.1 %, respectively, of the
control value (P < 0.001) (Fig. 3B).
Pre-treatment of P. fluorescens MF37 with BNP, CNP (10-6
M for 16 hours), dbcAMP or 8BcGMP (10-5 M for 16
hours) did not significantly modify the binding of bacte-
ria to glial cells (data not shown).
Effect of BNP and CNP on intra-bacterial cyclic AMP and 
cyclic GMP concentrations
The concentration of cyclic AMP (cAMP) in P. fluorescens
MF37 in late exponential phase was 15.4 ± 3.0 pmol/ml.
When P. fluorescens was incubated with BNP (10-6 M, 30
min) the concentration of cAMP increased to 22.9 ± 2.1
pmol/ml (48.7 % above the basal level; P < 0.01) (Fig.
4A). CNP (10-6 M, 30 min) had no significant effect (P >
0.05) on the intra-bacterial concentration of cAMP in P.
fluorescens. The concentration of cyclic GMP (cGMP) in P.
fluorescens MF37 was 0.28 ± 0.02 pmol/ml, and thus lower
than that of cAMP; furthermore, this value was in the
same range as the sensitivity of the assay. BNP (10-6 M, 30
min) did not significantly modify the cGMP concentra-
tion in P. fluorescens, whereas CNP (10-6 M, 30 min)
caused an increase to 0.66 ± 0.15 pmol/ml of cGMP (136
% higher than the basal level; P < 0.01) (Fig. 4B).
Effects of stable analogues of cAMP and cGMP on the 
cytotoxicity of the lipopolysaccharide of Pseudomonas 
fluorescens MF37
LPS makes a large contribution to the cytotoxicity of Pseu-
domonas  on glial cells [8]. We therefore evaluated the
effects of stable analogues of cyclic nucleotides on LPS
activity. The cytotoxicity of the LPS from P. fluorescens
exposed to dibutyryl cyclic AMP (dbcAMP) or 8-bromo-
cyclic GMP (8BcGMP) (10-5 M for 4 h at 28°C) was com-
pared to that of the LPS from control bacteria taken at the
same stage of growth (early stationary phase). LPS from
control and pre-treated bacteria were extracted and their
concentrations were determined by a KDO assay. The
mean concentrations of LPS samples from bacterial cul-
tures grown in the absence (3.3 μg/ml) or presence of
cAMP or cGMP (2.5 μg/ml and 4.1 μg/ml, respectively)
were all in the same range. Equivalent aliquots were
added to the culture medium (to give a final concentra-
tion of 500 ng/ml) of glial cells and cytotoxicity was deter-
mined, as previously described, by measurement of the
concentration of NO- 
2 (Fig. 5A) and by measurement of
LDH release (Fig. 5B). When glial cells were exposed to
LPS extracted from control P. fluorescens MF37, the NO- 
2
concentration was 19.2 ± 1.4 μM (n = 9); the value
obtained for LPS from P. fluorescens exposed to dbcAMP
was significantly higher (P < 0.05) at 23.3 ± 1.5 μM (n =
11) (Fig. 5A) whereas that for LPS from P. fluorescens
exposed to 8BcGMP was not significantly different to the
value for LPS from control MF37 (Fig. 5A). Necrosis in
glial cell cultures, in this series of experiments, affected 6.4
± 1.1 % of the control cell population in 24 h (n = 8) (Fig.
5B). For glial cells exposed to LPS extracted from control
P. fluorescens MF37, 29.2 ± 4.9 % of the cells displayed
signs of necrosis. For glial cells treated with LPS from
Cytotoxic activities of P. fluorescens MF37 treated with cyclic  nucleotide analogues Figure 3
Cytotoxic activities of P. fluorescens MF37 treated 
with cyclic nucleotide analogues. Effect of dibutyryl 
cyclic AMP (dbcAMP) and 8-bromo cyclic GMP (8BcGMP) 
(10-5 M) on the apoptotic (A) and necrotic (B) activities of 
Pseudomonas fluorescens MF37. The apoptotic effect of the 
bacterium was determined by measuring the accumulation of 
NO2
- in the medium resulting from the activation of inducible 
NO synthase activity in glial cells. The necrotic activity of the 
bacterium was assessed by measuring the accumulation of 
lactate dehydrogenase (LDH) in the medium resulting from 
rupture of the cytoplasmic membrane of glial cells. Values are 
expressed as mean concentrations of NO2
- or LDH in the 
culture medium after 24 h of incubation with untreated (n = 
32) or treated (n = 24 for dbcAMP, and n = 22 for 8BcGMP) 
bacteria. Data are means for four independent experiments. 
*** : Significantly different (P < 0.001).
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MF37 exposed to dbcAMP, 61.7 ± 10.4 % (P < 0.05) of the
cell population was affected by necrosis (Fig. 5B). In con-
trast, LPS from MF37 exposed to 8BcGMP did not cause
significantly more necrosis than control LPS (35.4 ± 3.6 %
of the cell population affected, P > 0.05). Control tests
with extracts of nutrient broth medium (ONB) obtained
using the same LPS extraction and purification protocols
indicated that the effect of the LPS on glial cell viability
was not due to contaminants from the extraction buffers
employed for purification (data not shown).
Effect of stable analogues of cAMP and cGMP on the 
structure of the lipopolysaccharide of Pseudomonas 
fluorescens MF37
LPS extracted and purified from P. fluorescens MF37 was
analysed by micellar electrokinetic chromatography
(MEKC), a technique that allows the separation of non-
volatile macro-molecules showing small differences of
size and polarity with an efficiency in the same range as
gas chromatography [18]. The LPS of P. fluorescens MF37
grown in control conditions gave numerous peaks (a to f,
Fig. 6A). Peaks a and b were minor peaks with retention
times of 7.0 and 11.1 min, respectively, each apparently
corresponding to a single molecular form. Peak c was
larger, with a retention time of 18.0 min and correspond-
ing to a series of compounds with very closely related
Effect of natriuretic peptides on intra-bacterial concentration  of monophosphate cyclic nucleotides Figure 4
Effect of natriuretic peptides on intra-bacterial con-
centration of monophosphate cyclic nucleotides. 
Effect of brain natriuretic peptide (BNP) and C-type natriu-
retic peptide (CNP) (10-6 M) on the intra-bacterial concen-
tration of cyclic AMP (cAMP) (A) and cGMP (B) in 
Pseudomonas fluorescens MF37. Data are means for three 
independent experiments (n = 9) ** : Significantly different (P 
< 0.01). NS: Not significantly different.
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Cytotoxic activity of LPS from Pseudomonas fluorescens MF37  treated with cyclic nucleotide analogs Figure 5
Cytotoxic activity of LPS from Pseudomonas fluores-
cens MF37 treated with cyclic nucleotide analogs. 
Effect of treatment of P. fluorescens MF37 with dibutyryl cyclic 
AMP (dbcAMP) and 8-bromo cyclic GMP (8BcGMP) on the 
apoptotic (A) and necrotic (B) activity of its LPS. The apop-
totic effect of the LPS was determined by measurement of 
the accumulation of NO2
- in the medium resulting from the 
activation of inducible NO synthase activity in glial cells. The 
necrotic action of the LPS was assessed by measurement of 
the accumulation of lactate dehydrogenase (LDH) in the 
medium resulting from rupture of the cytoplasmic membrane 
of glial cells. Values are expressed as mean concentrations of 
NO2
- or LDH in the culture medium after 24 h of incubation 
with untreated (n = 9) or treated (n = 11 for dbcAMP, and n 
= 11 for 8BcGMP) LPS (500 ng.ml-1). Data are means for 
three independent experiments. * : Significantly different (P < 
0.05). NS: Not significantly different.
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structures. Peak d was broad, with a retention time
between 21.3 and 24.6 min and presented a large variety
of molecular forms (Fig. 6A). Peaks e and f were high and
thin, with retention times of 26.3 and 32.2 min, respec-
tively. The electropherograms of LPS extracted from P. flu-
orescens MF37 treated with dbcAMP and 8BcGMP (10-5 M
for 4 h at 28°C) presented marked differences, although
the same major peaks (c, d and f) were detected in all elec-
tropherograms (Fig. 6B and 6C). The major difference
between LPS extracted from control and dbcAMP-treated
bacteria was the smaller number of molecular forms after
dbcAMP treatment (Fig. 6B): the broad spectrum of com-
pounds (peak d) was substantially smaller whereas a new
peak (g) appeared (Fig. 6B); the composition of com-
pounds corresponding to the broad peak (c) appeared to
be different and a new peak (h) appeared, corresponding
to a weakly retained molecular form (Fig. 6B). The struc-
ture of the LPS extracted from 8BcGMP-treated bacteria
was also different: a broad signal (i) corresponding to
numerous new strongly retained compounds was found
(Fig. 6C); in contrast as observed with dbcAMP-treated
LPS, a compound eluting as peak b was detected.
Discussion
We first tested for any direct antibacterial effect of the
natriuretic peptides BNP and CNP on Pseudomonas fluores-
cens. The concentration of the natriuretic peptides was
that usually employed to investigate the physiological
activity of these molecules in eukaryotic cells [19] and
identical to that previously tested on P. aeruginosa [10].
Because the cultivation method can greatly influence the
survival of bacteria [20], we decided to distinguish
between possible effects of BNP and CNP on growth on
liquid and solid substrates. Bacterial growth curves and
counting demonstrated that BNP and CNP had no effect
on the growth or cultivability of P. fluorescens in our exper-
imental conditions. This finding diverges from those of
previous studies showing an antimicrobial activity of BNP
[21] and suggesting a similar effect of CNP [22]. However,
the previously described activity of BNP appeared essen-
tially targeted towards Gram-positive bacteria; the mini-
mum inhibitory concentration of BNP for Pseudomonas
was 40 times that employed in our experiments [21].
Other than the structural homologies with anti-microbial
peptides, the only reason for suspecting that CNP
expresses bactericidal activity is that it can form channels
in artificial lipid bilayers [22]. However, artificial mem-
branes made of pure phospholipids are very different to
the double and LPS-decorated membranes of Gram-nega-
tive bacteria. Moreover, in physiological conditions CNP
is probably not present in sufficient concentrations to act
as an ionophore.
As these natriuretic peptides were without effect on the
survival of P. fluorescens, we used a well-characterised
model of glial cell infection [6,8] to investigate the effect
of BNP and CNP on the virulence of the bacteria. P. fluo-
rescens was incubated with one or other natriuretic pep-
tide during exponential growth, rinsed and then added to
primary cultures of glial cells. Thus, eukaryotic cells were
never exposed to the peptides and the effects observed can
only result from changes in the virulence of the bacteria.
We first showed that treatment of P. fluorescens by BNP
and CNP decreased its apoptotic effect on glial cells. This
suggests that the natriuretic peptides altered the bacterial
physiology sufficiently to modify the production of viru-
lence factors without affecting growth and survival. This is
in agreement with studies showing that anti-microbial
substances can exert other effects on bacterial physiology
or on toxins without inhibiting the survival of the micro-
organism [23,24]. Also, as described for P. aeruginosa [10],
BNP and CNP treatment of P. fluorescens increased its
necrotic activity. Necrosis is due to disruption of the cyto-
MEKC analysis of LPS from Pseudomonas fluorescens MF37  treated with cyclic nucleotide analogs Figure 6
MEKC analysis of LPS from Pseudomonas fluorescens 
MF37 treated with cyclic nucleotide analogs. MEKC 
analysis of LPS extracted from control (A), dbcAMP (10-5 M)-
treated (B) and 8BcGMP (10-5 M)-treated (C) P. fluorescens 
MF37. EOF, electo-osmotic flux. Arrows and numbers refer 
to the different molecular forms identified in the LPS from P. 
fluorescens MF37.
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plasmic membrane, generally due to enzymatic activities,
whereas apoptosis is a process induced by the production
of cell death messengers. We have previously shown that
the two mechanisms are differently regulated by P. fluores-
cens [17]. As suggested by Jungas et al. [25] a rapid and
strong induction of necrosis can mask other apoptotic
processes. Indeed, in our experimental conditions, the
increase in NOS activity appears only 10 hours after the
initial contact between glial cells and bacteria, whereas
LDH release was markedly increased within 4 hours (data
not shown). This necrosis may be triggered by bacterial
secretion of cytotoxic enzymes or virulence factors. In sup-
port of this hypothesis it was recently shown that MFN
1032, a clinical strain of P. fluorescens [4], secrets extracel-
lular factors, including a phospholipase C, with lytic
potential in the same range as that of P. aeruginosa [26].
Note that the increase of bacterial virulence due to treat-
ment by natriuretic peptides was not associated with an
increase in bacterial adhesion to the target cells and there-
fore does not appear to be contact mediated. Nevertheless,
variations in the efficiency of toxin translocation through
a type III secretion system would also explain our results;
P. aeruginosa expresses a type III secretion system [27], but
no such system in P. fluorescens MF37 has been described.
In order to go further into the mechanism involved in the
modulation of P. fluorescens cytotoxicity by natriuretic
peptides, we studied the effects of stable analogues of
cyclic nucleotide monophosphate. We used cell-permea-
ble stable analogues of cGMP and cAMP as tools to
explore the action of BNP and CNP in P. fluorescens, in
view of possible analogy with the mechanisms of action of
natriuretic peptides in eukaryotes. Indeed, in these cells
the effects of natriuretic peptides are mediated by three
different receptor subtypes, NPR-A, NPR-B and/or NPR-C
which are all associated with adenylate or guanylate
cyclase activities [28,29]. We observed that exposure of P.
fluorescens to 8-bromo-cyclic GMP (8BcGMP) and dibu-
tyryl cyclic AMP (dbcAMP) fully reproduced the dual
effect of BNP and CNP, i.e. a decrease of apoptosis and an
increase of necrosis. The involvement of cAMP in the reg-
ulation of host-directed virulence factors, through the
cAMP binding protein Vfr, has been demonstrated for P.
aeruginosa [30], but the effects of cGMP were unknown
until now. In P. aeruginosa, the Vfr protein may be acti-
vated by both cAMP and cGMP, as Vfr is unlikely to dis-
criminate between the two types of cyclic nucleotide [31].
Note that a cyclic nucleotide recognition module, called
"GAF" and present in a wide range of species from bacteria
to human, has been described [32]. This module binds
both cAMP and cGMP and it is possible that some cyclic
nucleotide binding proteins in bacteria do not discrimi-
nate between the two types of cyclic nucleotide mono-
phosphate. The involvement of a cyclic nucleotide-
dependent cascade in the action of natriuretic peptides in
P. fluorescens was confirmed by a direct assay of cAMP and
cGMP: BNP provoked a significant rise in the cAMP con-
centration in the bacterial stroma but was without effect
on cGMP. Conversely, CNP induced an increase of the
intra-bacterial concentration of cGMP but not that of
cAMP. These findings are noticeably different from those
for P. aeruginosa in which BNP has no effect on the cAMP
concentration [10]. Thus, it is suggesting that the sensitiv-
ity to natriurectic peptides diverges between Pseudomonas
species. P. fluorescens and P. aeruginosa therefore have dif-
ferent responses to BNP and CNP and consequently it is
likely that there are at least two forms of putative natriu-
retic-peptide sensor in Pseudomonas  species. Consistent
with this notion, the bacterium Helicobacter pylori can rec-
ognise only one of the subtypes of the somatostatin recep-
tor agonists and thus displays highly stereospecific
recognition of this eukaryotic messenger [13]. Here, we
demonstrate for the first time, that cGMP, a ubiquitous
eukaryotic second messenger, is involved in the regulation
of an intra-bacterial transduction signal. This illustrates
the remarkable analogy between the effects of natriuretic
peptides in eukaryotes and prokaryotes. The number of
adenylyl and guanylyl cyclases identified in bacteria is
now substantial [33] and is consistent with our observa-
tions: bacterial cyclase(s) may be involved in the response
of P. fluorescens to natriuretic peptides suggesting that in
addition to the well-characterised bacterial second mes-
senger, cyclic di-GMP [34], cyclic monophosphate nucle-
otides may play crucial roles in the integration of
environmental signals transmitted from the bacterial sur-
face.
The Pseudomonas endotoxin, LPS, is a major virulence fac-
tor released upon bacterial death, but can also be pro-
duced as vesicular forms by living bacteria [35,36]. The
composition of the LPS produced by P. fluorescens can
change rapidly under stress conditions [17]. We studied
the effects of the stable and cell-permeable analogues of
cyclic nucleotide monophosphate on the cytotoxic activi-
ties and chemical properties of the LPS. It would have
been preferable to use the natriuretic peptides themselves
but the cost was prohibitive in regard of their consump-
tion by such experiments that require producing massive
concentrations of LPS. Modifications of the LPS structure
are directly associated with differences in its pro-necrotic
activity [8,17], but did not affect the pro-apoptotic effect
of the endotoxin (this study). Thus, endotoxin-induced
cell death may be ascribed to at least two distinct proc-
esses. Bacterial-induced cell death is undoubtedly even
more complex as it may involve not only apoptosis and
necrosis, but also from the more recently described pyrop-
totic system [37]; furthermore, a single factor or micro-
organism can simultaneously induce different death types
[38]. This and previous works with P. fluorescens [8,17]
suggest that the expression of the LPS componentsBMC Microbiology 2008, 8:114 http://www.biomedcentral.com/1471-2180/8/114
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involved in the initiation of necrosis may be regulated
through a cAMP-dependent intra-bacterial pathway,
whereas pro-apoptotic factors are regulated by a different
mechanism. As observed in P. aeruginosa [10], greater
cytotoxicity of the LPS appeared to be associated with a
decrease in the diversity of the LPS isoforms. Further
investigations will be necessary to confirm if the lipid A
part of the LPS from P. fluorescens, like its counterpart in P.
aeruginosa PAO1 [10], is the target of the modification
associated with the intra-bacterial cyclic nucleotide con-
centration.
Conclusion
We demonstrate the existence of a natriuretic peptide sen-
sor mechanism in Pseudomonas fluorescens and the involve-
ment of cyclase(s) in the response to BNP and CNP. For
the first time we report that cGMP, in addition to cyclic di-
GMP and cAMP, may be involved in the coupling of the
bacterial response to specific extracellular messengers.
This work opens a wide range of possibilities for research
concerning the reasons for preservation – or common
emergence – of a natriuretic peptide-dependent receptor/
sensor system during evolution in eukaryotes and
prokaryotes. Studies of the physiological role of natriu-
retic peptides in bacteria will undoubtedly be informative.
Our work also suggests that the number of sensor or com-
munication molecules recognised by Gram-negative bac-
teria has been probably substantially underestimated.
Methods
Reagents and test substances
Dulbecco's Modified Eagle's Medium (DMEM) and
Ham's F12 culture medium, HEPES buffer, poly-L-lysine,
insulin, dibutyryl cyclic AMP (dbcAMP), 8-bromo-cyclic
GMP (8BcGMP), and human BNP were purchased from
Sigma-Aldrich (St Quentin Fallavier, France). CNP pep-
tide was from NeoMPS (Strasbourg, France). Foetal calf
serum, L-glutamine and antibiotic-antimycotic solutions
were obtained from Biowhittaker (Emerainville, France).
The kit Cytotox 96 was purchased from Promega (Char-
bonnières, France).
Bacterial cultures
Pseudomonas fluorescens MF37 is a biovar V, naturally
rifampicin-resistant mutant of the psychrotrophic strain
MF0 selected in our laboratory [39]. The strain was grown
in nutrient Broth n°2 medium (ONB) (AES, Bruz, France)
at 28°C. For pre-treatment with natriuretic peptides or
cyclic nucleotide analogues, bacteria were transferred to
10 ml ONB and the test substances were added at the
beginning of the exponential phase; the cultures were
then grown for 5 h. Just before the infection assays, bacte-
ria in early stationary phase were harvested by centrifuga-
tion in an Eppendorf centrifuge tube (6000 rpm for 4 min
at 20°C) and resuspended at a cell density of 106 CFU/ml,
in glial cell culture medium without antibiotics or antimy-
cotics. The density of the bacterial suspension was deter-
mined by measuring absorption at 580 nm using a
spectrophotometer (ThermoSpectronics, Cambridge,
UK). The bacterial density and the absence of contamina-
tion were verified by plating. The effects of natriuretic pep-
tides on bacterial growth kinetics were studied at 28°C.
The natriuretic peptides (BNP or CNP; 10-6  M) were
administered either immediately at the start of the experi-
ment or at the beginning of the early stationary phase. To
determine the effects of natriuretic peptides on bacterial
cultivability, P. fluorescens MF37, taken at the beginning of
the stationary phase, was incubated for 5 h with BNP or
CNP (10-6 M) and then plated.
Primary cultures of glial cells
Newborn rats obtained by mating in the laboratory were
decapitated 48 – 72 h after birth under sterile conditions.
All animal manipulations were performed under the
supervision of qualified investigators and in authorised
animalery (Agreement n° AGEXP27.01). The brain was
quickly extracted and rinsed in glial culture medium con-
sisting of DMEM/Ham's medium (2 : 1) supplemented
with 10 % foetal calf serum, 2 mM glutamine, 0.001 %
insulin, 5 mM Hepes, 0.3 % glucose and 1 % antibiotic –
antimycotic solution. The meninges were removed and
the telencephalon was carefully dissected, immersed in
glial culture medium and mechanically dispersed for 5
min by gentle aspiration through a sterile needle. The sus-
pension was filtered through a sterile 82 μm pore-size
nylon filter to remove the remaining tissue fragments. The
cells were counted and 105 cells were layered in each 1.9
cm2 well coated with poly-L-lysine 50 μg/ml. Glial cells
were incubated at 37°C in a 5 % CO2 humidified atmos-
phere and were allowed to grow for 9 to 14 days, so as to
obtain confluent cells in all culture wells. The culture
medium was changed the first day after plating and then
every 2 days.
The binding index (adhesive behaviour) of P. fluorescens
MF37 on glial cells was investigated using the gentamicin
assay adapted from that used to quantify P. aeruginosa
invasion of epithelial cells [40].
Measurement of the nitric oxide (NO) synthase activity of 
glial cell
NO synthase activity of glial cells is an indirect marker of
apoptosis that has been previously validated by Annexin
V and propidium iodide double staining observations
using staurosporin as a positive control to visualise
cytoskeletal rearrangement [8]. NO synthase activity was
assayed by measuring the accumulation of nitrites (NO2
-)
in the culture medium using a technique derived from the
Griess colorimetric reaction [41]. To allow the accumula-
tion of nitrite in the medium, the assays were performedBMC Microbiology 2008, 8:114 http://www.biomedcentral.com/1471-2180/8/114
Page 9 of 11
(page number not for citation purposes)
after 24 h of incubation of glial cells with control or pre-
treated bacteria. The Griess reagent was prepared extem-
poraneously by mixing equal volumes of N-(1-naphtyl)
ethylenediamine and sulphanilic acid. This solution was
mixed (V/V) with 500 μl of cell culture supernatant fil-
tered through a 0.22 μm pore-size filter. After incubation
for 30 min at room temperature, the absorbance was
measured at 548 nm. A standard curve was obtained by
serial dilution of a solution of NaNO2 from 100 to 2 μm.
The linearity of the assay between these concentrations
was verified and the concentrations in the assay were kept
between these values. The intra- and between-assay coeffi-
cients of variation were lower than 3 and 8 %, respec-
tively.
Measurement of the release of cytosolic lactate 
dehydrogenase (LDH) by glial cells
Lactate dehydrogenase (LDH) is a stable cytosolic enzyme
released into the culture medium upon cell lysis. Its use as
an indicator of necrosis in glial cells has been validated by
epifluorescence observations using SDS as a positive con-
trol [8]. The amount of LDH released by eukaryotic cells
in the presence of the bacteria was determined using the
Cytotox 96® enzymatic assay (Promega, Charbonnières,
France). Glial cells were incubated for 24 h with control or
pre-treated P. fluorescens MF37 at a concentration of 106
CFU/ml. A lysis buffer, consisting in a solution of Triton
X-100 (9 % in water), was employed to determine the
maximum of LDH possibly released by glial cells in our
experimental conditions (100 % LDH release). A back-
ground level was established using culture medium alone,
and defined as 0% LDH release, to eliminate the contribu-
tion of the culture medium. The percentage of LDH
release in the cell population was then calculated using
the equation:
(OD = Optical Density)
The assay was sufficiently sensitive to measure a concen-
tration of LDH equivalent to the lysis of 1 % of the cell
population.
Determination of intra-bacterial cyclic AMP and cyclic 
GMP
The concentrations of cyclic AMP (cAMP) and cyclic GMP
(cGMP) in bacteria exposed to natriuretic peptides were
determined using cAMP and cGMP direct enzyme immu-
noassay kits from Sigma RBI (Saint-Quentin Fallavier,
France). Aliquots of P. fluorescens (106 CFU/ml) in late
exponential phase were incubated for 30 min at 28°C in
10 ml ONB containing BNP or CNP (10-6 M). The bacteria
were then centrifuged (6 min at 6.000 rpm) and the pel-
lets were resuspended in physiological water and boiled
for 10 min. These extracts were ultra-centrifuged (1 h at 62
000 g) to remove cell debris and then lyophilised. Dried
residues were resuspended in 1 ml of water and assayed
for cAMP or cGMP according to the supplier's protocol.
Lipopolysaccharide extraction and purification
LPS was purified from Pseudomonas fluorecens MF37
according to a procedure based on that of Darveau and
Hancock [42]. Briefly, bacteria in early stationary phase
were harvested by centrifugation (6 000 × g for 10 min at
20°C). The pellets were suspended in 10 mM Tris-buffer
containing 2 mM MgCl2, 200μg/ml pancreatic DNase and
50μg/ml pancreatic RNase, and subjected to four bursts of
sonication of 30s at a probe density of 70. The suspension
was then incubated for 2 h at 37°C and tetrasodium-
EDTA, Tween 20 and tris-hydrochloride were added. The
sample was centrifuged (10 000 × g, 30 min, 20°C) to
remove peptidoglycan and the supernatant was incubated
overnight with protease, at 37°C, with constant shaking.
Two volumes of 0.375 M MgCl2 in 95% ethanol were
added and the mixture was cooled to 0°C. The sample was
then centrifuged (12 000 × g, 15 min, 0°C) and the pellet
was sonicated in a solution of Tween 20 and tetrasodium-
EDTA. The pH of the solution was lowered to 7, to prevent
lipid saponification. The solution was incubated for 30
minutes at 85°C, to ensure that outer membrane proteins
were denatured, and the pH of the solution was increased
to 9.5. Protease was then added and the sample was incu-
bated overnight at 37°C. Two volumes of 0.375 M MgCl2
in 95% ethanol were added and the sample was centri-
fuged (12 000 × g for 15 min at 0°C). The pellet was resus-
pended in 10 mM Tris-HCl, sonicated and centrifuged
twice to remove insoluble Mg2+-EDTA crystals. The super-
natant was then ultracentrifuged (62 000 × g for 2 h at
15°C) and the pellet, which contained LPS, was resus-
pended in distilled water and used for KDO assays. The
control extraction buffer was prepared by the same proce-
dure, but starting with sterile ONB medium.
Capillary electrophoresis of lipopolysaccharide
Purified bacterial LPS was analysed by micellar electroki-
netic chromatography (MEKC), using a Beckman P/ACE
5510 system equipped with a diode-array detector (detec-
tion range: 190–600 nm, wavelength of the curves pre-
sented: λ = 203 nm) and refrigerated injection system. A
fused-silica capillary tube (50 μm i.d. × 57 cm; 50 cm to
detector) from Beckman Coulter (Villepinte, France) was
used: it was installed in a refrigerated cartridge and condi-
tioned with 1 N NaOH for 4 h before rinsing and equili-
bration with running buffer. The separation buffer for
MEKC consisted of 25 mM boric acid (pH 9.00) supple-
mented with sodium dodecyl sulphate (80 mM). The
potential used for separation (25 kV) was identified in
preliminary experiments as the limit of linearity of the
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curve for the current-voltage relationships. Samples were
injected by N2 hydrostatic pressure (0.5 psi, 20 s) and ana-
lysed over a 30-minute period.
Statistics
Each value reported for the assays is the mean of measure-
ments of a minimum of nine samples from a minimum of
three independent preparations. The non parametric
Mann-Whitney test was used to compare the means
within the same set of experiments.
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